Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
139
-
Total 13F shares, excl. options
-
24.9M
-
Shares change
-
-89.6K
-
Total reported value, excl. options
-
$249M
-
Value change
-
-$1.79M
-
Put/Call ratio
-
2.49
-
Number of buys
-
65
-
Number of sells
-
-41
-
Price
-
$10.01
Significant Holders of ANAVEX LIFE SCIENCES CORP. - COM NEW (AVXL) as of Q2 2022
165 filings reported holding AVXL - ANAVEX LIFE SCIENCES CORP. - COM NEW as of Q2 2022.
ANAVEX LIFE SCIENCES CORP. - COM NEW (AVXL) has 139 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.9M shares
.
Largest 10 shareholders include BlackRock Inc. (5.35M shares), STATE STREET CORP (4.49M shares), VANGUARD GROUP INC (3.99M shares), GEODE CAPITAL MANAGEMENT, LLC (1.31M shares), MORGAN STANLEY (845K shares), NORTHERN TRUST CORP (712K shares), CITADEL ADVISORS LLC (700K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (524K shares), MARSHALL WACE, LLP (424K shares), and Pier Capital, LLC (384K shares).
This table shows the top 139 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.